Apollomics Doses First Patient in a Phase I Clinical Trial of APL-102
10 Aug 2021 //
PRESS RELEASE
Apollomics Doses First Patient in a Phase I Clinical Trial of APL-102
10 Aug 2021 //
PRESS RELEASE
10 Aug 2021 //
PRESS RELEASE
10 Aug 2021 //
PRESS RELEASE